This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
Avatar

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and Refractory Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Douglas Johnson
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Douglas Johnson
415 views
June 7, 2024

Chapters

NADINA Study & Neoadjuvant Therapy

00:00

1L Metastatic: Triplet Immunotherapy & TIL

05:13

Refractory Melanoma: TIL & Viral Therapies

07:01

Survivability & Therapy Sequencing Insights

09:23

0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: Skin Videos

05:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical…

Feat. L. Burton
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
View All

Related Content

AUTOPLAY
Melanoma Research Foundation

13th Annual CURE OM Global Science Meeting

Wed, Oct 9, 2024
See 1 other
20:09
Scripps Health

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
09:00
AAD 2024

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
10:01
AAD 2024

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

Feat. V. Sondak
27:38
Oncology Data Advisor

Sun Safety and Melanoma Awareness: Expert Tips on Preventing Sun Dam…

Feat. T. Knight, M. Hadfield
09:26
Oncology Data Advisor

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Feat. M. Hadfield
22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Ou…

Feat. H. Tawbi
18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
14:42
Jeff Yorio

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
11:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We B…

Feat. P. Corrie
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
55:10
University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

Feat. C. Lieu
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde